Two Sigma Advisers’s ENZON PHARMACEUTICALS INC ENZN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2016
Q2 | – | Sell |
-14,700
| Closed | -$7K | – | 2298 |
|
|
2016
Q1 | $7K | Hold |
14,700
| – | – | ﹤0.01% | 2016 |
|
|
2015
Q4 | $10K | Sell |
14,700
-5,600
| -28% | -$3.81K | ﹤0.01% | 1848 |
|
|
2015
Q3 | $20K | Buy |
+20,300
| New | +$20K | ﹤0.01% | 1777 |
|
|
2015
Q1 | – | Sell |
-165,119
| Closed | -$180K | – | 2350 |
|
|
2014
Q4 | $180K | Sell |
165,119
-17,000
| -9% | -$18.5K | ﹤0.01% | 1921 |
|
|
2014
Q3 | $197K | Buy |
182,119
+27,100
| +17% | +$29.3K | ﹤0.01% | 1613 |
|
|
2014
Q2 | $161K | Sell |
155,019
-5,300
| -3% | -$5.5K | ﹤0.01% | 1778 |
|
|
2014
Q1 | $165K | Buy |
160,319
+40,023
| +33% | +$41.2K | ﹤0.01% | 1616 |
|
|
2013
Q4 | $140K | Buy |
120,296
+14,477
| +14% | +$16.8K | ﹤0.01% | 1680 |
|
|
2013
Q3 | $178K | Sell |
105,819
-6,800
| -6% | -$11.4K | ﹤0.01% | 1450 |
|
|
2013
Q2 | $225K | Buy |
+112,619
| New | +$225K | ﹤0.01% | 1362 |
|